2nd CEE Meeting on Viral Hepatitis and Co-infection with HIV – Presentations

Thursday 6 October
Session 1: Country-specific presentations
 
Local situation in Romania
Dr. O. Sandulescu, Carol Davila University of Medicine and Pharmacy, Romania
 
Local situation in Ukraine
Dr. P. Skala, Alliance for Public Health, Ukraine
 
Local situation in the Baltic countries
Dr. S. Caplinskas, Centre For Communicable Diseases and AIDS, Lithuania
 
Local situation in Slovenia and the Balcan countries
Dr. M. Maticic, University of Ljubljana Medical Faculty, Slovenia
 
Local situation in Poland
Dr. M. Parczewski, Pomeranian Medical University, Poland
 
Local situation in Czech and Slovak Republics
Dr. V. Aster, Hospital Na Bulovce, Czech Republic
 
Local situation in Georgia
Dr. A. Abutidze Infectious Diseases, AIDS and Clinical Immunology Research Center, Georgia
 
Local situation in Turkey
Dr. C. Yurdaydin University of Ankara Medical School, Turkey
 
Local situation in Russia
Dr. V. Rassokhin, Saint-Petersburg City AIDS center, Russia
Session 2: Management of Hepatitis B
 
State-of-the-art treatment of Hepatitis B
Dr. C. Yurdaydin, University of Ankara Medical School, Turkey
 
Prospects for Cure
Dr. P. Kennedy, Royal Free Hospital, United Kingdom
 Abstract presentations
  The effect of lamivudine- versus tenofovir-containing antiretroviral regimen on hepatitis B infection in a cohort of HIV infected long term survivors
Dr. A. Temereanca, National Institute for Infectious Diseases Prof Dr Matei Bals, Romania
  The prevalence of HBV, HCV and HIV infection in Romania - a nationwide screening program for surveillance of viral infections and Prevalence of risk factors for HBV and HCV infection in two young cohorts in Romania
Dr. O. Sandulescu, Carol Davila University of Medicine and Pharmacy, Romania
Session 3: Management of Hepatitis Delta
 
Update of new drugs
Dr. C. Yurdaydin, University of Ankara Medical School, Turkey
Friday 7 October
Session 4: Treatment Challenges in HCV -- special populations
 
Intravenous Drug Users
Dr. P. Khaykin, MainFachArzt, Germany
 
Drug-Drug Interactions: considerations
Dr. A. Streinu-Cercel, National Institute for Infectious Diseases Prof Dr Matei Bals, Romania
Special session: HIV in Special Populations (ViiV)
 
Tackling the issues: Caring for HIV-positive women today
Dr. A. M. Geretti, University of Liverpool, Institute of Infection and Global Health, United Kingdom
 
HIV and Pediatrics in Central Europe
Dr. M. Mărdărescu, National Institute for Infectious Diseases Prof Dr Matei Bals, Romania
 Session 5 Abstract presentations - Co-infection
 Expression of NS4 HCV in liver cells of HIV/HCV co-infected patients
Dr. N. Matsiyeuskaya, Grodno State Medical University, Belarus
 HCV reinfection in HCV/HIV coinfected patients treated for VHC in AIDS Center Prague
Dr. V. Aster, Hospital Na Bulovce, Czech Republic
 Chronic Hepatitis C Treatment among HIV/HCV co-infected PWID in Ukraine: community-supported treatment model experience
Dr. T. Barnard, Alliance for Public Health, Ukraine
 Quality of life in patients with HCV/ HIV co-infection
Dr. O. Shevchenko, Dnipropetrovsk Medical Academy, Ukraine
 Predictors of HIV co-infection in HCV infected patients in Serbia
Dr. M. Stanojevic, University of Belgrade, Serbia
Session 5 Co-infection
 

Cost-efficiency versus Potency
Dr. A. Streinu-Cercel, National Institute for Infectious Diseases Prof Dr Matei Bals, Romania